Wahrnehmung und Optimierungsmöglichkeiten klinischer Studien aus Sicht der Patientinnen

Autor: Christian Löhberg, PA Fasching, CM Bayer, CC Hack, MP Lux, FC Thiel, SM Jud, Thomas B. Hildebrandt, Bani, A Hein, S Knetzger, MW Beckmann

Publikováno v: Senologie - Zeitschrift für Mammadiagnostik und -therapie. 9

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::49919afc3ebf720dc5b0e5c864092c55
https://doi.org/10.1055/s-0032-1313469

Kosten-Nutzwert-Analyse endokriner Therapien in der adjuvanten Situation der postmenopausalen Patientin mit einem hormonrezeptorpositiven Mammakarzinom auf Basis der Überlebensdaten und Berücksichtigung zukünftiger generischer Preise aus der Sicht des deutschen Gesundheitswesens

Autor: MP Lux, C Reichelt, J Karnon, TD Tänzer, D Radosavac, PA Fasching, MW Beckmann, FC Thiel

Publikováno v: Geburtshilfe und Frauenheilkunde. 71

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::738c4ac7f4631aa4daedd985034b3ef4
https://doi.org/10.1055/s-0031-1278567

Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.

Autor: Gass P; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany. Electronic address: paul.gass@uk-erlangen.de., Thiel FC; Department of Gynecology and Obstetrics, Alb Fils Clinics, Klinik am Eichert, Göppingen, Germany., Häberle L; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany; Biostatistics Unit, Department of Gynecology and Obstetrics, Erlangen University Hospital, Erlangen, Germany., Ackermann S; Department of Gynecology and Obstetrics, Klinikum Darmstadt, Darmstadt, Germany., Theuser AK; Institut für Frauengesundheit GmbH, Erlangen, Germany., Hummel N; Institut für Frauengesundheit GmbH, Erlangen, Germany., Boehm S; Institut für Frauengesundheit GmbH, Erlangen, Germany., Kimmig R; Department of Gynecology and Obstetrics, Essen University Hospital, Essen, Germany., Reinthaller A; Department of Gynecology and Gynecologic Oncology, AKH Vienna University Hospital, Vienna, Austria., Becker S; Department of Gynecology and Obstetrics, Frankfurt University Hospital, Frankfurt am Main, Germany., Hilpert F; Onkologisches Therapiezentrum, Krankenhaus Jerusalem, Hamburg, Germany., Janni W; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany., Vergote I; Department of Gynaecology and Obstetrics, Division of Gynaecological Oncology, Leuven University Hospitals, Leuven, Belgium., Harter P; Department of Gynecology & Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany., Emons J; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Hein A; Department of Gynaecology and Obstetrics, Klinikum Esslingen, Esslingen, Germany., Beckmann MW; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Fasching PA; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Pöschke P; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2024 Apr; Vol. 183, pp. 25-32. Date of Electronic Publication: 2024 Mar 14.

Risk of postmenopausal hormone therapy and patient history factors for the survival rate in women with endometrial carcinoma.

Autor: Hein A; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center, Friedrich Alexander University of Erlangen-Nuremberg, Universitaetsstrasse 21-23, 91054, Erlangen, Germany. alexander.hein@uk-erlangen.de., Schneider MO; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center, Friedrich Alexander University of Erlangen-Nuremberg, Universitaetsstrasse 21-23, 91054, Erlangen, Germany., Renner SK; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center, Friedrich Alexander University of Erlangen-Nuremberg, Universitaetsstrasse 21-23, 91054, Erlangen, Germany., Fasching PA; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center, Friedrich Alexander University of Erlangen-Nuremberg, Universitaetsstrasse 21-23, 91054, Erlangen, Germany., Fiessler C; Department of Medical Informatics, Biometry and Epidemiology, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany., Titz S; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center, Friedrich Alexander University of Erlangen-Nuremberg, Universitaetsstrasse 21-23, 91054, Erlangen, Germany., Hartmann A; Institute of Pathology, Erlangen University Hospital, Erlangen, Germany., Beckmann MW; Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center, Friedrich Alexander University of Erlangen-Nuremberg, Universitaetsstrasse 21-23, 91054, Erlangen, Germany., Thiel FC; Department of Gynecology and Obstetrics, ALB FILS KLINIKEN GmbH, Klinik am Eichert, Goeppingen, Germany.

Publikováno v: Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2020 Jan; Vol. 301 (1), pp. 289-294. Date of Electronic Publication: 2019 Dec 19.

Retraction Note: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app.

Autor: Koch MC; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany. martin.koch@uk-erlangen.de., Lermann J; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., van de Roemer N; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., Renner SK; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., Burghaus S; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., Hackl J; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., Dittrich R; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., Kehl S; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., Oppelt PG; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., Hildebrandt T; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., Hack CC; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., Pöhls UG; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., Renner SP; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany., Thiel FC; Frauenklinik, Universitätsklinikum, Erlangen, Universitaetsstrasse 21-23, 91,054, Erlangen, Germany.

Publikováno v: Reproductive health [Reprod Health] 2019 May 14; Vol. 16 (1), pp. 54. Date of Electronic Publication: 2019 May 14.